Companies: 10,795·Total market cap: $144.5T
GAN Limited

GAN Limited

GANNASDAQConsumer Cyclical
$1.97
+$0.00(+0.00%)
Market Cap$91526988
P/E Ratio
52W High$1.97
52W Low$1.29
Overview

GAN Limited (GAN) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · GAN · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.13B$0.13B$0.14B$0.13B$0.04B
Cost of Revenue$0.04B$0.04B$0.04B$0.04B$0.01B
Gross Profit$0.09B$0.09B$0.10B$0.08B$0.02B
Gross Margin %(computed)70.05%70.10%70.58%67.02%70.22%
Operating Expenses
R&D Expenses$0.00B$0.04B$0.03B$0.02B$0.01B
G&A Expenses$0.03B$0.04B$0.05B$0.05B$0.02B
Total Operating Expenses$0.10B$0.12B$0.12B$0.11B$0.04B
Operating Income($0.00B)($0.03B)$0.14B($0.03B)($0.02B)
Operating Margin %(computed)-2.67%-23.42%101.08%-20.34%-55.38%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.34B$0.00B$0.00B
Income Before Tax($0.01B)($0.03B)($0.19B)($0.03B)($0.02B)
Income Tax Expense($0.00B)$0.00B$0.00B($0.00B)$0.00B
Net Income($0.01B)($0.03B)($0.20B)($0.02B)($0.02B)
Net Margin %(computed)-5.90%-26.61%-139.55%-19.85%-57.50%
Per Share & EBITDA
EPS (Basic)$-0.18$-0.78$-4.66$-0.59$-0.75
Wtd Avg Shares0.05B0.04B0.04B0.04B0.03B
EBITDA$0.00B($0.01B)($0.01B)($0.01B)($0.02B)
EBITDA Margin %(computed)3.03%-10.16%-5.38%-8.69%-46.11%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more GAN Limited data

About GAN Limited (GAN) Income Statement

GAN Limited (GAN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, GAN reported revenue of $0.13B, gross profit of $0.09B (gross margin 70.05%), and net income of ($0.01B) — a net profit margin of -5.90%.

Frequently asked questions

GAN · 4 questions

GAN Limited (GAN) reported revenue of $0.13B for 2024, up 4.3% year-over-year.

GAN revenueGAN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09